Skip to main content
Premium Trial:

Request an Annual Quote

New Spaces in Connecticut

Connecticut is beginning to see the effects of its investment into biotech, the Associated Press reports.

Funds from the nearly $900 million Bioscience Connecticut initiative — which was part of Governor Dannel Malloy's plan to bolster the state's biomedical industry — has gone toward the building of new labs and buildings for tech and biomedical startups, the AP notes. The initiative also attracted a branch of the Jackson Laboratory for Genomic Medicine to the UConn campus.

Some 18 new companies are opening up shop in lab in the Cell and Genome Science Building on the University of Connecticut Health campus, the AP says. One new company, Shoreline Biome, which has availed itself of UConn's incubation program, which included help finding venture capital connections, interns, and equipment, is developing a product to help researchers and clinicians map patients' microbiomes.

"We're making the kind of investments that quite frankly should have been made decades ago," Malloy said at the lab ribbon-cutting ceremony last week, according to the AP. "We know that a lot of companies can be started here. Now, we're going to be concentrating on starting them here, having them grow here and keeping them here."

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.